US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Seneca Biopharma Inc (SNCA)
Seneca Biopharma Inc (SNCA) ニュース

SNCA

Seneca Biopharma (SNCA)

Seneca Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNCA

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/06/15	07 : 23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07 : 45	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/14	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/06/09	22 : 39	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/28	19 : 17	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/27	19 : 01	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	05 : 52	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04 : 41	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04 : 37	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/22	04 : 35	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/06	07 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/04/06	07 : 50	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/03/23	06 : 05	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/03/13	20 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/02/16	06 : 41	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/02/14	06 : 35	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/25	20 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/19	20 : 01	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/14	07 : 11	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/05	07 : 19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2023/01/05	01 : 00	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/12/17	06 : 52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/11/17	01 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/11/14	22 : 44	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/18	05 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/15	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc
2022/10/08	02 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCA	Seneca Biopharma Inc

Showing the most relevant articles for your search:NASDAQ:SNCA

1 2 3 4 5 6 7 8 次へ >>

Nova Lithium (PK)

SPDR S&P US Dividend Ari...

ITUBS368 Ex:35,47

Robeco Sustainable Globa...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約